<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Cardiology/Ischemic%20Heart%20Disease/Thrombotic%20Disease/Spontaneous%20Coronary%20Artery%20Dissection/">
    <link rel="shortcut icon" href="../../../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Background - MedNotes</title>
    <link href="../../../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../../../js/jquery-3.2.1.min.js"></script>
    <script src="../../../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../../../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Background", url: "#_top", children: [
              {title: "Epidemiology, Pathophysiology, Genetics", url: "#epidemiology-pathophysiology-genetics" },
          ]},
          {title: "Presentation and Diagnosis", url: "#presentation-and-diagnosis", children: [
          ]},
          {title: "Acute Management of SCAD", url: "#acute-management-of-scad", children: [
              {title: "Revascularization", url: "#revascularization" },
              {title: "Medical Therapy", url: "#medical-therapy" },
          ]},
          {title: "References", url: "#references", children: [
          ]},
        ];

    </script>
    <script src="../../../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../../../Percutaneous%20Assist%20Devices/Active%20MCS/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../../../Percutaneous%20Assist%20Devices/Active%20MCS/" class="btn btn-xs btn-link">
        Active Mechanical Circulatory Systems
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../STEMI/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../STEMI/" class="btn btn-xs btn-link">
        STEMI
      </a>
    </div>
    
  </div>

    

    <h1 id="background">Background</h1>
<ul>
<li>SCAD is emerging an important cause of <a href="../ACS/">MI</a> particularly in younger women</li>
<li>SCAD is a nonathersclerotic, nontraumatic cause of <a href="../ACS/">ACS</a> and SCD</li>
<li>high level evidence based guidance is lacking</li>
</ul>
<h2 id="epidemiology-pathophysiology-genetics">Epidemiology, Pathophysiology, Genetics</h2>
<ul>
<li><strong>Typical patient:</strong> middle aged woman, few traditional CV risk factors. However, occurs in late teens to 90s. Underlying factors include sex, hormonal fluctuations, arteriopathies, genetics, precipitants (environment, physical, emotional)<ul>
<li>Women (87-95%)</li>
<li>Middle-aged (44-53 years mean age)</li>
<li>White (but in all backgrounds as well)</li>
<li>May be lacking hypertertension, hyperlipidemia, smoking as risk factors (same as general matched population proportion)</li>
</ul>
</li>
<li><strong>Prevalence of 4% in all <a href="../ACS/">ACS</a> and up to 35% of all <a href="../ACS/">ACS</a> in women &lt; 50 years of age</strong></li>
<li><strong>Pathophysiology</strong><ul>
<li>acute coronary artery event</li>
<li>development of hematoma within tunica media -- separation of the intimal complex from the underlying vessel and compression of the true lumen causing ischemia and AMI</li>
<li>two hypotheses<ul>
<li>(1) "inside-out" --Â  development of an intimal flap, and blood enters from the true lumen</li>
<li>(2) "outside-in" -- hematoma arises de novo in the media from disruption of traversing microvessels. This is MORE LIKELY. Hematomas are PRESSURED and precede development of flap.\</li>
</ul>
</li>
</ul>
</li>
<li><strong>Genetics</strong><ul>
<li>associated with some SNPs - related to monogenic changes; +familial risk</li>
<li><em>FMD</em> is associated with SCAD</li>
</ul>
</li>
<li><strong>Sex hormones</strong><ul>
<li>Temporally, SCAD has been reported to occur just before or during menstruation while taking hormonal contraceptives and postmenopausal hormone therapy and in women with a history of infertility and/or prior or current treatment for infertility.</li>
<li>unknown MOA</li>
</ul>
</li>
<li><strong>Pregnancy-associated SCAD (P-SCAD)</strong> occurs at any time during or after pregnancy  <ul>
<li>70% occur post-partum, usually within 1st week</li>
<li>typically more severe/multivessel presentation</li>
<li>comprises up to 1/6 of SCAD overall</li>
<li>associated with older age at first childbirth, multigravidas</li>
</ul>
</li>
</ul>
<p><a href="http://medreference.ca/uploads/images/gallery/2022-02/ieT1NlUHnFe9jBn5-image-1644456746246.png"><img alt="image-1644456746246.png" src="http://medreference.ca/uploads/images/gallery/2022-02/scaled-1680-/ieT1NlUHnFe9jBn5-image-1644456746246.png" /></a></p>
<h1 id="presentation-and-diagnosis">Presentation and Diagnosis</h1>
<ul>
<li><strong>Triggers</strong><ul>
<li>pregnancy, as above</li>
<li>extreme physical or emotional stress</li>
</ul>
</li>
<li><strong>Clinical presentation</strong><ul>
<li>similar to atherosclerotic <a href="../ACS/">ACS</a>  <ul>
<li>chest pain or equivalent symptoms</li>
<li>elevated serial biomarkers and ECG findings c/w <a href="../ACS/">NSTEMI</a>/<a href="STEMI">STEMI</a></li>
<li>cardiogenic shock, ventricular arrhythmias, SCD</li>
</ul>
</li>
<li>therefore, Dx often missed in this patient population</li>
</ul>
</li>
<li><strong>Diagnosis</strong><ul>
<li><strong>Catheter-based coronary angiography</strong><ul>
<li>the primary and typically only necessary modality for diagnosis of SCAD</li>
<li>predilection for mid-to-distal coronary arteries, most commonly LAD</li>
<li>higher risk features<ul>
<li>multivessel involvement</li>
<li>severe stenosis</li>
<li>isolated intramural hematoma</li>
</ul>
</li>
</ul>
</li>
<li><strong>Intravascular and noninvasive imaging</strong><ul>
<li>Not really used. Options are IVUS, OCT, CMR, <a href="../../Diagnosis%20and%20Screening/Coronary%20CT%20Angiography/">CCTA</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<h1 id="acute-management-of-scad">Acute Management of SCAD</h1>
<p>Goals are (1) restore/preserve myocardial perfusion and function (2) avoid adverse outcomes related to thrombolysis.</p>
<p><a href="http://medreference.ca/uploads/images/gallery/2022-02/ERNstXi4ZblEjoiu-image-1644457890102.png"><img alt="image-1644457890102.png" src="http://medreference.ca/uploads/images/gallery/2022-02/scaled-1680-/ERNstXi4ZblEjoiu-image-1644457890102.png" /></a></p>
<h2 id="revascularization">Revascularization</h2>
<h2 id="medical-therapy">Medical Therapy</h2>
<ul>
<li>There are no RCTs to guide SCAD-specific pharmacologic management. Treatment is based on sequelae and associated risks<ul>
<li>LV dysfunction --&gt; <a href="../../../Heart%20Failure/GDMT/Guideline-Directed%20Medical%20Therapy/">GDMT</a><ul>
<li>beta blocker associated with less SCAD recurrence</li>
</ul>
</li>
<li>PCI with stent --&gt; standard post-PCI DAPT therapy</li>
<li>Hypertension --&gt; antihypertensives</li>
<li>Hyperlipidemia --&gt; <em>primary prevention</em> guidelines (no association with SCAD)</li>
</ul>
</li>
<li>Discontinue systemic anticoagulation/GP IIb-IIIa inhibitors once the Dx of SCAD is made, unless there are other indications for systemic anticoagulation or there is an apparent intraluminal thrombus</li>
</ul>
<p>Anti-thrombotic therapy for SCAD is not guided by strong evidence, but consider <strong>DAPT for 2-4 weeks then low-dose ASA for 3-12 months total</strong>. Decisions about further therapy should be individualized based on comorbidities and individual risk profile.</p>
<h1 id="references">References</h1>
<ol>
<li>Hayes SN, Tweet MS, Adlam D, et al. Spontaneous Coronary Artery Dissection. <em>Journal of the American College of Cardiology</em>. 2020;76(8):961-984. doi:<a href="https://doi.org/10.1016/j.jacc.2020.05.084">10.1016/j.jacc.2020.05.084</a></li>
</ol>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../../../Percutaneous%20Assist%20Devices/Active%20MCS/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../../../Percutaneous%20Assist%20Devices/Active%20MCS/" class="btn btn-xs btn-link">
        Active Mechanical Circulatory Systems
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../STEMI/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../STEMI/" class="btn btn-xs btn-link">
        STEMI
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>